Aplicações de CRISPR/Cas9 no tratamento de doenças inflamatórias intestinais
CRISPR/Cas9, uma tecnologia revolucionária de edição genética, holds immense potential in treating Inflammatory Bowel Disease (DII). By precisely targeting and modifying genes responsible for IBD pathogenesis, CRISPR/Cas9 offers promising therapeutic avenues to alleviate inflammation, control immune responses, and promote tissue regeneration.







